Ingrid W van der Cruijsen

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

Harry J de Koning, Gerrit Draisma, H. D. de Koning, 2003, Journal of the National Cancer Institute.